- Home
- ITGR vs RNA Comparison
ITGR vs RNA Comparison
Compare ITGR & RNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITGR
- RNA
- Stock Information
- Founded
- ITGR 1970
- RNA 2012
- Country
- ITGR United States
- RNA United States
- Employees
- ITGR N/A
- RNA N/A
- Industry
- ITGR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- RNA Biotechnology: Pharmaceutical Preparations
- Sector
- ITGR Health Care
- RNA Health Care
- Exchange
- ITGR Nasdaq
- RNA Nasdaq
- Market Cap
- ITGR 3.6B
- RNA 4.0B
- IPO Year
- ITGR 2000
- RNA 2020
- Fundamental
- Price
- ITGR $74.51
- RNA $48.39
- Analyst Decision
- ITGR Strong Buy
- RNA Strong Buy
- Analyst Count
- ITGR 8
- RNA 17
- Target Price
- ITGR $136.75
- RNA $69.53
- AVG Volume (30 Days)
- ITGR 1.1M
- RNA 1.7M
- Earning Date
- ITGR 10-23-2025
- RNA 11-07-2025
- Dividend Yield
- ITGR N/A
- RNA N/A
- EPS Growth
- ITGR N/A
- RNA N/A
- EPS
- ITGR 2.31
- RNA N/A
- Revenue
- ITGR $1,794,800,000.00
- RNA $10,729,000.00
- Revenue This Year
- ITGR $10.92
- RNA N/A
- Revenue Next Year
- ITGR $7.35
- RNA $108.74
- P/E Ratio
- ITGR $32.02
- RNA N/A
- Revenue Growth
- ITGR 9.64
- RNA 1.23
- 52 Week Low
- ITGR $66.50
- RNA $21.51
- 52 Week High
- ITGR $146.36
- RNA $56.00
- Technical
- Relative Strength Index (RSI)
- ITGR 20.35
- RNA 54.51
- Support Level
- ITGR $102.20
- RNA $46.29
- Resistance Level
- ITGR $111.99
- RNA $49.50
- Average True Range (ATR)
- ITGR 3.98
- RNA 2.59
- MACD
- ITGR -1.40
- RNA -0.10
- Stochastic Oscillator
- ITGR 17.61
- RNA 46.20
About ITGR Integer Holdings Corporation
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The company also develops batteries used in nonmedical applications in the energy, military, and environmental markets. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns more than half of its revenue in the United States.
About RNA Avidity Biosciences Inc.
Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.